Non-opioid Pain Patch Market size was valued at USD 3.61 billion in 2024 and is likely to reach USD 6.16 billion by the end of 2037, registering around 4.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of non-opioid pain patch is assessed at USD 3.73 billion. The reason behind the growth is due to the growing burden of diabetes across the globe. Diabetic neuropathy may present as the initial symptom of diabetes caused by excessive blood sugar levels that harm the nerves resulting in pain and discomfort in the hands, feet, or limbs.
According to the World Health Organization (WHO), around 422 million individuals globally suffer from diabetes, and the disease is directly responsible for roughly 1.5 million fatalities annually.
The growing development of advanced products is believed to fuel the non-opioid pain patch market growth. For instance, A scientific team led by Duke University has created a biocompatible polymer patch surgical patch that dissolves after releasing non-opioid medicines and it is assumed that during the crucial period following surgery, the patch should be able to manage wound discomfort for three or four days.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.2% |
|
Base Year Market Size (2024) |
USD 3.61 billion |
|
Forecast Year Market Size (2037) |
USD 6.16 billion |
|
Regional Scope |
|
Product Type (Lidocaine Patch, Diclofenac Patch, Methyl Salicylate Patch, Capsaicin Patch, Ketoprofen Patch)
The lidocaine patch segment is estimated to account for 69% share of the global non-opioid pain patch market by 2037 owing to the growing incidence of chronic pain. An increasing number of people worldwide are affected by chronic pain, which can endure for months or years and disrupts day-to-day activities such as working, socializing, and taking care of others.
In order to lessen the intensity of all typical pain characteristics including arthritis, disk-related pain, and chronic lower back pain, and reduce opioid use in individuals, patch such as lidocaine patch can be used which are offered in both OTC and prescription strength formulations. According to estimates, in the US more than 6% of people experienced high-impact chronic pain in 2021.
Besides this, the capsaicin patch segment in the non-opioid pain patch market is anticipated to gain a noteworthy share in the coming years. Capsaicin is the component that gives chili peppers their heat and also what gives them their burning and irritating sensation. The pepper's seeds contain a significant amount of this unusual, organic compound and the hotter a pepper is, the more capsaicin it contains which acts as a pain reliever and the main component of pepper spray.
Qutenza, a high-dose capsaicin patch that has been licensed in recent years, to treat diabetic peripheral neuropathy (DPN) of the feet and to reduce the pain associated with postherpetic neuralgia.
Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
The online pharmacies segment in the non-opioid pain patch market is set to garner a notable share. The non-narcotic painkiller patch that are filled with painkilling medicine used for chronic painful disorders are easily accessible to the public through online pharmacies. Moreover, regardless of location, patients can acquire their pain patch from licensed pharmacists online, which not only makes purchasing more convenient nonetheless also benefits many consumers monetarily and is accompanied by a guarantee of the customer's safety and security.
Additionally, the non-opioid pain patch market from hospital Pharmacies, and retail pharmacies segment are poised to jointly hold notable shares during the forecast period. Retail pharmacies offer a large selection of prescription medications and over-the-counter pain patch to alleviate discomfort. Furthermore, hospital pharmacies frequently provide specialized services that improve patients' quality of life overall, working in tandem with doctors and other healthcare providers.
Our in-depth analysis of the global non-opioid pain patch market includes the following segments:
|
Product Type |
|
|
Distribution Channel |
|
North American Market Forecast
Non-opioid pain patch market in North America is predicted to account for the largest share of 51% by 2037 propelled by the presence of key players which has led to the development of new products. For instance, in October 2020 Vizuri Health Sciences Consumer Healthcare Inc. an innovative healthcare facility in Maryland, USA, launched a groundbreaking New Pain Relief PatchBloc24 Flexi-Stretch Pain Tape with 4-way stretch fabric and potent anesthetic to numb the pain, making it perfect for use on moving joints, including elbows and knees.
European Market Statistics
The Europe non-opioid pain patch market is estimated to be the second largest, during the forecast timeframe led by a higher prevalence of stress. For instance, Greece has over 6% frequency of depression in Europe, and more than 55% of people in the country are reported to have frequent stress. This may drive the demand for non-opioid pain patch in the region since people with stress usually experience migraine which causes pain behind one eye or in the area surrounding the temples and lasts for hours or days.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?